Cryopreservation Equipment Market to Surpass US$ 11.60 Billion Threshold by 2025 Globally

The global Cryopreservation Equipment Market, by Equipment (Freezers (Cryopreservation Freezers, Drystore Freezers), Incubators, Sample Preparation System, and Accessories), by Cryogen (Liquid Nitrogen, Oxygen, Argon, and Liquid helium), by Application (Cord Blood Stem Cells, Sperms, Semen & Testicular Tissues, Embryos & Oocytes, Other Application), by End User (Stem Cells Banks, Biotechnology and Pharmaceutical organizations, Contract Research Organizations, Stem Cell Research Laboratories, and Research and Academic Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 4.318.1 million in 2017 and is projected to exhibit a CAGR of 13.2% over the forecast period (2017–2025).

Cryopreservation equipment are used to cryopreserve biological samples by preventing the dehydration and formation of intracellular ice crystals. Cryopreservation equipment includes controlled rate freezers, freezing racks and holders, cryogenic incubators, cryopreservation loading chambers and tanks, thermocouple sensor for temperate detection, storage sample chambers, vapor and liquid phase storage, and canister and cane systems.

Moreover, the increasing demand for fertility treatment such as in-vitro fertilization (IVF) treatment and therapies for women and higher effectiveness of frozen embryos in the IVF procedures are expected to drive growth of the cryopreservation equipment market. For instance, research findings published in the TIME Health, in January 2018, conducted a study including 3,000 women in Vietnam who underwent IVF procedures, and were randomly assigned to receive frozen or fresh embryo. 36% of the women implanted with frozen embryo had live births, as compared to the 31% of them who were implanted with fresh embryo. Additionally, researchers at the Penn State College of Medicine, conducted a five-week study on women suffering from polycystic ovarian syndrome (PCOS). Those who received frozen embryos during the in-vitro fertilization recorded safer and more successful pregnancies than those who received fresh embryos. Frozen embryos lowered the risk of ovarian hyperstimulation syndrome by 7.1% to 10.3%, as compared to using fresh embryos. Freezing embryos offers couples the advantage of genetic testing, to reduce the chance of the genetic diseases prior implantation of the embryo. The umbilical cord blood (UCB) stem cells is non-invasive alternative source of hematopoietic stem cells to treat a variety of blood and bone marrow diseases, blood cancers, metabolic disorders, and immune deficiencies. Umbilical cord blood is required to be collected at the time of birth and be cryopreserved for future applications. However, low awareness regarding the benefits of preserving umbilical cord banking (UCB), limits its application in the long run, thereby limiting growth of the cryopreservation equipment market.

A study published as the Banking Umbilical Cord Blood (UCB) Stem Cells: awareness, attitude and expectations of donor, in the National Center for Biotechnology Information (NCBI), in May 2016, showed that pregnant women in emerging economies show lower awareness regarding UCB. The study was conducted on 300 women, among whom only 26.5% were aware of UCB, 31% were aware of the private cord blood banking, while only 16% were aware of public cord blood banking.

Browse 43 Market Data Tables and 48 Figures spread through 180 Pages and in-depth TOC on “Cryopreservation Equipment Market by Equipment (Freezers (Cryopreservation Freezers, Drystore Freezers), Incubators, Sample Preparation System, and Accessories), by Cryogen (Liquid Nitrogen, Oxygen, Argon, and Liquid helium), by Application (Cord Blood Stem Cells, Sperms, Semen & Testicular Tissues, Embryos & Oocytes, Other Application), by End User (Stem Cells Banks, Biotechnology and Pharmaceutical organizations, Contract Research Organizations, Stem Cell Research Laboratories, and Research and Academic Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)” - Global Forecast to 2025

To know the latest trends and insights prevalent in the cryopreservation equipment market, click the link below:

https://www.coherentmarketinsights.com/market-insight/cryopreservation-equipment-market-1356

Key Takeaways of the Cryopreservation Equipment Market:

The global cryopreservation equipment market is expected to exhibit a CAGR of 13.2% over the forecast period, owing to increasing numbers IVF procedures
Among equipment, the freezers segment is estimated to hold a dominant position in the market in 2017, as the freezers are an inevitable equipment used in most of the cryopreservation procedures.
Among cryogen, the liquid nitrogen segment holds a dominant position, owing to the increasing adaptation of liquid nitrogen for preserving biological samples in vapor and liquid phases for longer periods of time
Among applications, the cord blood stem cells segment is the largest segment, owing to increasing number of patients undergoing IVF procedures
Among end users, the stem cell research laboratory segment holds a dominant position in the market, owing to increasing application of stem cells in the treatment of various diseases, such as leukemia, hematopoietic disorders, and autoimmune disease.

Some of the key players operating in the cryopreservation equipment market are Thermo Fisher Scientific, Inc., Custom Biogenic Systems, Chart Biomedical Co. Ltd., Merck KGaA, Barber-Nichols Inc., Praxair Technology, Inc., Linde LLC, Planer PLC, Cryologic Pty. Ltd., Charter Medicals, Nikkiso Cryo Inc., Cryogenic Control, and Haimen United Laboratory Equipment Development Co., Ltd.